Show notes
This week on The Genetics Podcast, Patrick is joined by Dr. Luke Pilling, Senior Lecturer in Genetic Epidemiology at the University of Exeter. They discuss hemochromatosis and the case for earlier diagnosis, and the genetic drivers of multimorbidity, pharmacogenetics, and drug response.Show Notes0:00 Intro to The Genetics Podcast00:59 Welcome to Luke 01:37 An overview of HFE hemochromatosis and why diagnosis is delayed 04:24 Iron levels and overload risk in heterozygous and compound heterozygous carriers05:51 Aging-related effects seen in homozygotes 06:43 How hemochromatosis is currently diagnosed and detected in the UK09:26 Future screening and case finding, including the Our Future Health cohort11:28 Genetic and environmental factors that shape outcomes in C282Y homozygotes 13:28 The GEMINI project and the genetic drivers of multimorbidity15:56 Drug targets from multimorbidity genetics, including repurposing and opposite effects18:49 Using disease sequences in health records to look for earlier intervention points in multimorbidity21:21 Data gaps limiting multimorbidity research, from primary care records to proteomics23:17 Handling misdiagnosis and clinical code accuracy in health record research24:55 International collaborations and the need for more diverse biobank data26:08 Pharmacogenetics research and how genetic variants shape drug response29:04 Limited clinical examples of pharmacogenetics and lessons from non-responders33:08 Genetics of lifespan and healthy aging, and why geroscience pathways rarely appear in GWAS36:06 Luke’s future research focuses 40:39 Closing remarksFind out more:- Hereditary hemochromatosis study- Multimorbidity study- Pharmacogenetics framework study



